I guess our logic runs along different lines. Something is wrong when a company performs like this and for so long (in Amedicas case, since inception). To me it's crystal clear, and it's not getting resolved soon unless you luck out with a merger or buyout. Even then, most investors will have lost big time...but at least the downward cycle abates. Proving oneself correct through a technicality is not my thing. I've had my share of losers, but I've learned to open my eyes. You go back and forth to prove your point, whether on the share bit or the company's superior products but the bottom line is, you and the others are losing your shirts because....
Market Data 
Markets 
AI
